DDrare
Disease
Drug
Target Gene/Pathway
お問合せ先
EN
Reduced Glutathione 100mg
( DrugBank: - / KEGG DRUG: - )
1 disease
告示番号
疾患名
(ページ内リンク)
臨床試験数
6
パーキンソン病
1
6. パーキンソン病
臨床試験数
:
2,307
/
薬物数
:
2,007
- (
DrugBank
:
349
) /
標的遺伝子数
:
188
-
標的パスウェイ数
:
199
10
50
100
ALL
trials per page:
Showing 1 to 1 of 1 trials
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
NCT02424708
(
ClinicalTrials.gov
)
April 2015
20150400
15/4/2015
20150415
Phase IIb Study of Intranasal
Glutathione
in Parkinson's Disease
Phase IIb Study of Intranasal
Glutathione
in Parkinson's Disease
Parkinson's Disease
Drug:
Reduced
Glutathione
100mg
;Drug:
Reduced
Glutathione
200mg;Drug: Placebo
Bastyr University
Michael J. Fox Foundation for Parkinson's Research
Completed
21 Years
N/A
Both
45
Phase 2
United States